1. Forghanifard, Mohammad Mahdi, Rad, Abolfazl, Farshchian, Moein, Moghbeli, Meysam, Abbaszadegan, Mohammad Reza. 2016. TWIST1 upregulates the MAGEA4 oncogene. In Molecular carcinogenesis, 56, 877-885. doi:10.1002/mc.22541. https://pubmed.ncbi.nlm.nih.gov/27533647/
2. Zhu, Weijian, Yi, Qiang, Chen, Zheng, Zhong, Jianing, Zhong, Jinghua. 2025. Exploring the role and mechanisms of MAGEA4 in tumorigenesis, regulation, and immunotherapy. In Molecular medicine (Cambridge, Mass.), 31, 43. doi:10.1186/s10020-025-01079-8. https://pubmed.ncbi.nlm.nih.gov/39905312/
3. Fujiwara-Kuroda, Aki, Kato, Tatsuya, Abiko, Takehiro, Shiku, Hiroshi, Hirano, Satoshi. 2018. Prognostic value of MAGEA4 in primary lung cancer depends on subcellular localization and p53 status. In International journal of oncology, 53, 713-724. doi:10.3892/ijo.2018.4425. https://pubmed.ncbi.nlm.nih.gov/29901069/
4. Wei, Xiaoxiao, Li, Zhangfu, Zheng, Heng, Yang, Hongyu, Shen, Yuehong. 2024. Long non-coding RNA MAGEA4-AS1 binding to p53 enhances MK2 signaling pathway and promotes the proliferation and metastasis of oral squamous cell carcinoma. In Functional & integrative genomics, 24, 158. doi:10.1007/s10142-024-01436-6. https://pubmed.ncbi.nlm.nih.gov/39249547/
5. Tang, Wei-Wei, Liu, Zi-Hao, Yang, Tong-Xin, Wang, Han-Jin, Cao, Xiu-Feng. 2016. Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma. In OncoTargets and therapy, 9, 4289-93. doi:10.2147/OTT.S99195. https://pubmed.ncbi.nlm.nih.gov/27478386/
6. Chandora, Kapil, Chandora, Akshay, Saeed, Anwaar, Cavalcante, Ludimila. 2025. Adoptive T Cell Therapy Targeting MAGE-A4. In Cancers, 17, . doi:10.3390/cancers17030413. https://pubmed.ncbi.nlm.nih.gov/39941782/
智鼠故事 
